Incyte (INCY) EBT Margin (2010 - 2026)

Incyte's (INCY) quarterly EBT Margin came in at 44.89% in Q2 2026, down 101.0% YoY from 4489.23% in Q2 2025, and up 66.28% on a QoQ basis from 27.0% in Q1 2026.

Incyte (INCY) EBT Margin (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of EBT Margin data on file, last reported at 44.89% in Q2 2026.

  • Quarterly EBT Margin fell 101.0% year-over-year to 44.89% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 33.81% (up 627.0% YoY) and the FY2025 annual result came in at 32.37%, up 2491.0% from the prior year.
  • EBT Margin climbed to 44.89% in Q2 2026, from 27.0% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 45.91% in Q2 2025 to a low of 37.34% in Q2 2024.
  • A 5-year average of 21.13% and a median of 25.66% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2024 — EBT Margin tumbled 6642 bps — and 2025, when it soared 8325 bps.
  • Tracing INCY's EBT Margin over 5 years: stood at 8.7% in 2022, then soared by 207 bps to 26.74% in 2023, then decreased by 0 bps to 26.62% in 2024, then dropped by 3 bps to 25.88% in 2025, then surged by 73 bps to 44.89% in 2026.
  • The last three EBT Margin figures came in at 44.89% (Q2 2026), 27.0% (Q1 2026), and 25.88% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 44.89%

Historic Data

Download Data
DateValue
Jun 30, 2026 44.89%
Mar 31, 2026 27.00%
Dec 31, 2025 25.88%
Sep 30, 2025 35.31%
Jun 30, 2025 45.91%
Mar 31, 2025 22.24%
Dec 31, 2024 26.62%
Sep 30, 2024 13.76%
Jun 30, 2024 -37.34%
Mar 31, 2024 26.81%
Dec 31, 2023 26.74%
Sep 30, 2023 25.44%
Jun 30, 2023 29.08%
Mar 31, 2023 6.41%
Dec 31, 2022 8.70%
Sep 30, 2022 18.05%
Jun 30, 2022 25.17%
Mar 31, 2022 9.62%
Dec 31, 2021 13.91%
Sep 30, 2021 25.77%